Professor of Paediatric Haematology, University of Oxford
Professor of Bioinformatics, Barts Cancer Institute, Queen Mary University of London
Patient affiliate
Patient affiliate
Director, National Quantum Computing Centre
Professor of AI in Radiation Oncology, University of Cambridge Department of Oncology and Cambridge University Hospitals
Patient affiliate
Senior Vice President and Head of Oncology Translational Research, GSK
09:00–10:00 | Registration, networking and poster set-up |
10:00–10:15 | Welcome Catherine Elliott, Cancer Research UK John Marsh, use MY data |
10:15–10:55 | Keynote address: Quantum technologies for healthcare Michael Cuthbert, UK National Quantum Computing Centre |
10:55–11:25 | Networking break |
11:25–13:15 | Emerging technologies for cancer research: spotlight on quantum Co-Chairs: Michael Cuthbert, UK National Quantum Computing Centre Isabella Topley, patient advocate Speakers: Chris Phillips, Imperial College London/ Digistain Jan Lukas Robertus, Royal Brompton and Harefield hospitals Jack Hart, University of Cambridge Elica (Elitsa) Kyoseva, NVIDIA |
13:15–14:15 | Lunch and posters |
14:15–14:40 | Introduction to the CRUK Data Community Special Interest Groups Chair: Charlotte Palmer, Cancer Research UK Speakers: Mieke Van Hemelrijck, King’s College London Frances Pearl, University of Sussex Harriet Unsworth, CRUK national biomarker centre, University of Manchester |
14:40–15:55 | Roundtable sessions: What will the next five years of data driven cancer research look like? Improving the interoperability and reusability of CRUK-funded research data: the OMOP Common Data Model Facilitators: Charlotte Moss (Kings College London), Jasmine Handford (Kings College London), Andrew Blake (Kings College London)
CRUK Data Hub - A Sneak Peek Facilitators: Sarah Wooller (University of Sussex) and Andrew Levy (University of Sussex)
FAIR Play: Creating Reusable Data Assets for Cancer Research Facilitators: Chris Tso (Cancer Research UK) and Joe Day (Cancer Research UK)
What It Takes: Skills and Training for Future Data Careers in Cancer Research Facilitators: Colin McLean (University of Edinburgh) and Charlotte George (University of Oxford)
From Data Gaps to Data Diversity in Cancer Research Facilitators: Toral Gathani (University of Oxford) and Charlotte Misseldine (Data Science For Health Equity)
The sustainability challenge of digital health research Facilitators: Loïc Lannelongue (University of Cambridge) and Kirsty Pringle (Software Sustainability Institute, University of Edinburgh)
What are the priorities of the cancer data research community for the new Health Data Research Service? Facilitators: Gareth Price (University of Manchester), Charlotte Palmer (Cancer Research UK), Rebecca Holley (University of Manchester) and Alexis Webb (Health Data Research UK)
Spot the Hazards: Exploring Risks in Data-Driven Research Facilitators: Ceilidh Welsh (University of Cambridge) and Susana Roman Garcia (Health Information Consulting Ltd)
Developing Public Involvement and Engagement Skills for Data Research and Statistics Facilitators: Matt Howard-Murray (Cancer Research UK) and Samaira Khan (Health Data Research UK and PEDRI)
Get your patient here! Developing a national network of patient communities with use MY data Facilitators: Ceri Steele (use MY data) and Chris Carrigan (use MY data) |
15:55–16:25 | Networking break |
16:25–17:40 | Panel Driving the next era of cancer research: data and collaborative innovation Co-chairs: Catriona Hoey, patient advocate Panellists: Anita Grigoriadis Pharos AI Gregory Verghese, Pharos AI Lara Edwards, Health Data Research UK Ashley Akbari, Swansea University Sunil Dolwani, Cardiff University |
17:40–17:45 | Closing remarks Melissa Lewis-Brown, Cancer Research UK |
17:45–19:00 | Drinks and networking reception |
08:30–09:00 | Registration and networking |
09:00–09:10 | Welcome back Melissa Lewis-Brown, Cancer Research UK Nicolas Vinogradov-Wouters, patient advocate |
09:10–09:50 | Keynote Why children are key to responsible AI Mhairi Aitken, The Alan Turing Institute |
09:55–10:45 | Session 3 AI-enabled target/drug discovery Co-chairs: Ellen Bisci, patient advocate Speakers: Vanessa Smer Barreto, University of Edinburgh Flash talks: How strong is your driver? Machine learning and structural features predict driver mutation strength and clinical outcomes Noa Klugman, The Hebrew University of Jerusalem MANIFEST: multiomic platform for cancer immunotherapy Kevin Mulder, The Francis Crick Institute Bridging expert-led spatial–multimodal omics analysis and AI integration in the POETIC breast cancer trial (NCT02338310) Xixuan Zhu, The Institute of Cancer Research |
10:45–11:15 | Networking break |
11:15–12:50 | AI-accelerated early detection of cancer using imaging and multimodal data Co-chair: Raj Jena, University of Cambridge Ace Manthey, Amazon EU / patient affiliate Speakers: Yang Hu, University of Leicester Heba Sailem, King’s College London Konstantinos Zormpas-Petridis, Agostino Gemelli University Policlinic Flash talk: Use of AI for the early detection of upper GI cancers from routine blood tests Victoria Moglia, University of Leeds |
12:50–13:50 | Lunch and posters |
13:50–15:20 | Advances in AI and computation in personalised radiation therapy Co-chairs: Bill Nailon, University of Edinburgh Shaumya Kularajan, University of Glasgow Speakers: Andre Dekker, Maastro Clinic / Maastricht University Marianne Aznar, University of Manchester David Noble, Edinburgh Cancer Centre Flash talk: Predicting radiotherapy toxicity using machine learning and large datasets Tim Rattay, University of Leicester |
15:20–15:50 | Networking break |
15:50–16:50 | Panel AI in Population Genomics—where are we now, and where are we headed? Co-chairs: Richard Lee, The Royal Marsden and Institute of Cancer Research Early Diagnosis and Detection Centre Esme Radin, Edinburgh Western General Patients Group and ICPV Speakers: Kiley Graim, University of Florida Montserrat Garcia-Closas, Institute of Cancer Research |
16:55–17:40 | Keynote Agent AI and the future of drug discovery and development Bissan Al-Lazikani, The University of Texas MD Anderson Cancer Center |
17:40–17:45 | Closing remarks Melissa Lewis-Brown, Cancer Research UK |
17:45–19:00 | Networking drinks reception Bowl food provided |
08:30–09:00 | Registration |
09:00–09:10 | Welcome back Melissa Lewis-Brown, Cancer Research UK Libby Cooper, Data-Can |
09:10–09:50 | Keynote Why data matters: enabling large scale population health research in the UK in the 'big data' era Cathie Sudlow, University of Edinburgh |
09:55–10:20 | Flash talks on the power of health data in personalised medicine Co-chairs: Cathie Sudlow, University of Edinburgh Jak Howell, Trekstock Flash talks: QResearch primary care records linked to national hospital and cancer registry data for personalised medicine: a validation study Sanat Kulkarni, University of Oxford Subsequent primary cancers following colorectal cancer: a population-based retrospective cohort study using the English National Cancer Registry (1995–2022) and the English National Lynch Syndrome Registry Lucy Loong, The Institute of Cancer Research, London Independent contributions of specific Magnetic Resonance Imaging-quantified fat deposits to cancer incidence (UK Biobank): an expert consensus DAG-informed analysis Lee Malcomson, The University of Manchester |
10:20–10:50 | Networking break |
10:50–12:25 | Transforming medicine through digital twins Co-chairs: Tony Ng, GSK and King's College London Pippa Slater, Young Lives Vs Cancer Speakers: Walter Kolch, Systems Biology Ireland, University College Dublin Lena Granovsky, GSK Jasmin Fisher, UCL Cancer Institute Flash talk: Towards digital twins of cancer risk prediction- the pathways to cancer from cells the aging healthy tissue Benjamin Hall, UCL |
12:25–13:25 | Lunch and posters |
13:25–14:25 | Panel: balancing promise and risk - how do we best regulate digital twins and personalised medicine? Co-chairs: Mark Lawler, Queens University Belfast Debbie Keatley, patient advocate Speakers: Angela Aristidou, UCL/Stanford Irina Babina, Concr Daniel Morales, EMEA |
14:25–14:55 | Networking break |
14:55–15:45 | Is personalised medicine accessible to all? Biases and opportunities for diverse groups of patients Co-chairs: Melissa Davis, Morehouse School of Medicine Jak Howell, Trekstock Speakers: Anna Schuh, University of Oxford Flash talks: Cancer Burden and Services Accessibility across Europe: A Comparative Analysis Based on 2023 European Social Survey Data (ESS 11) Michael Chege, Bright Experts Statistics Services AI-defined Molecular Classifications in Ovarian Cancer (AAIMC-OC) for Equitable Access to Molecular Diagnostics Elaine Leung, University of Birmingham Inequalities in routes to diagnosis, time to diagnosis and time to treatment for individuals with breast cancer in England Tetyana Perchyk, University of Surrey |
15:50–16:35 | Closing keynote: From bias to breakthroughs: making precision medicine truly inclusive Melissa Davis, Morehouse School of Medicine |
16:40–16:50 | Closing remarks Catherine Elliott, Cancer Research UK |
Director of the Usher Institute, School of Population Health Sciences, The University of Edinburgh and Director of the UKRI Adolescent Health Study
Why data matters: Enabling large scale population health research in the UK in the 'big data' era
Senior Ethics Fellow, The Alan Turing Institute
Why children are key to responsible AI
Director, Institute of Translational Genomic Medicine, Morehouse School of Medicine
From bias to breakthroughs: making precision medicine truly inclusive
Professor of Genomic Medicine and Director of Therapeutics Data Science, Department of Genomic Medicine, MD Anderson Cancer Centre
Director, National Quantum Computing Centre
Senior Group Leader, Cancer Research UK Cambridge Institute
Day 2 - Revolutionising cancer research: the transformative role of AI
Professor of AI in Radiation Oncology, University of Cambridge Department of Oncology and Cambridge University Hospitals
Day 2 - Revolutionising cancer research: the transformative role of AI
Consultant Respiratory Physician, NIHR Biomedical Research Centre at The Royal Marsden and the Institute of Cancer Research
Day 2 - Revolutionising cancer research: the transformative role of AI
NHS Clinical Scientist
Professor, Department of Oncology Physics at the Edinburgh Cancer Centre
Day 2 - Revolutionising cancer research: the transformative role of AI
Director, Institute of Translational Genomic Medicine, Morehouse School of Medicine
Day 3 - Personalising cancer medicine: the power of health data
Senior Vice President and Head of Oncology Translational Research, GSK
Day 3 - Personalising cancer medicine: the power of health data
Professor of Digital Health, Queen’s University Belfast
Scientific Director, DATA-CAN
Day 3 - Personalising cancer medicine: the power of health data
